Fertility Services Market

The fertility services market is anticipated to expand from US$ 35.79 billion in 2024 to US$ 67.12 billion by 2031, with a projected CAGR of 9.3% during the period of 2025-2031.

Market Insights and Analyst Perspective:The growth of the fertility services market can be attributed to several factors, including improved accessibility and availability of healthcare services; enhanced success rates of in vitro fertilization (IVF) through ICSI for men with poor sperm quality; and increased investment in healthcare and research. Additionally, the rising incidence of infertility-related medical conditions such as polycystic ovary syndrome (PCOS), endometrial tuberculosis, and sexually transmitted diseases (STDs) is propelling market growth. Growing awareness about infertility and better access to healthcare facilities have also heightened the demand for these services in both developed and emerging nations. The surge in infertility-related health issues has significantly boosted the global market in recent years. Other contributing factors include rising disposable incomes, flexible health insurance coverage options, and increased marketing of reproductive services via television and online platforms. The report also highlights growth opportunities in light of current trends in the fertility services market, such as the rise in launches and approvals for fertility services and advancements in technology.

Growth Drivers:Rising Incidence of Gynecological Disorders Fuels Market Expansion

Conditions like blocked fallopian tubes, often resulting from untreated STIs, complications from abortions, postpartum infections, and surgical procedures, can lead to infertility in women. The increasing prevalence of various diseases, including endometrial tuberculosis, PCOS, and STDs, that contribute to infertility is driving the growth of the fertility services market. According to a study published in the Cureus Journal in August 2022, the global prevalence of PCOS among women is estimated to range from 4% to 20%. The World Health Organization (WHO) reported that in 2021, PCOS affected over 116 million women (3.4%) worldwide. Furthermore, a 2020 article in The Lancet estimated that 24 million women in China suffer from PCOS. This situation is increasing the demand for IVF and various assisted reproductive technologies (ART), thereby driving the growth of the fertility services market.

Strategic Insights

Report Segmentation and Scope:The analysis of the fertility services market is conducted based on procedure, patient type, end user, and geography. The market is segmented by procedure into assisted reproductive technology, artificial insemination, and fertility surgeries. By patient type, it is divided into male and female categories. Regarding end users, the market is segmented into fertility centers, hospitals & surgical clinics, and others.

Segmental Analysis:In terms of procedure, the fertility services market is divided into assisted reproductive technology, artificial insemination, and fertility surgeries. The assisted reproductive technology segment held the largest market share in 2023 and is expected to exhibit the highest CAGR from 2023 to 2031. This segment is further divided into in vitro fertilization, intracytoplasmic sperm injection, and surrogacy.

The fertility services market, categorized by patient type, is split into male and female segments. The female segment accounted for a larger market share in 2023, while the male segment is projected to experience a higher CAGR during the forecast period. Factors such as increased stress, obesity, smoking, and alcohol consumption contribute to male infertility. Additionally, rising awareness of fertility services, increased R&D spending, initiatives by key market players to launch new products, and changing lifestyles are driving growth in the male segment.

In terms of end users, the fertility services market is segmented into fertility centers, hospitals & surgical clinics, and others. The fertility centers segment held the largest market share in 2023 and is expected to register the highest CAGR during the forecast period. The growth in the number of fertility clinics globally, along with technological advancements, is propelling the market growth for this segment. Furthermore, increasing awareness of infertility treatments in both developed and emerging countries has led to a rise in the number of fertility treatment clinics worldwide, further driving market growth. The growing number of professionals capable of treating infertility, rising disposable incomes, and the increasing number of licensed fertility clinics in developing countries like India and China also contribute to the growth of the fertility centers segment.

Regional Analysis - Fertility Services Market:The fertility services market report covers North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). Asia Pacific held the largest market share in 2023 due to the introduction and rapid distribution of various infertility medications and increased research activities in the field of infertility.

Europe ranked third in terms of market share for fertility services in 2023. The market in this region is segmented into Germany, the UK, Italy, Spain, France, and the Rest of Europe. The presence of numerous domestic market players and the rising incidence of infertility are key factors driving market growth in this region. Germany is a significant contributor to the regional market. Europe is home to 40% of all IVF clinics globally, which has been a crucial factor in the success of the European fertility testing and treatment market. Additionally, the region has attracted substantial investments from global leaders. The overall outlook for the European market is positive, with advanced IVF technology drawing significant investment from private equity firms. Moreover, do-it-yourself testing has improved access and reduced the costs associated with infertility testing and treatment, both of which are expected to create lucrative opportunities for market growth in the coming years.

The fertility services market in Asia Pacific is projected to achieve the fastest CAGR from 2021 to 2031. The market in this region is segmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. The growth in China is driven by increasing medical tourism and enhancements in healthcare infrastructure, which are expected to boost the adoption of fertility services in the region. Additionally, technological advancements in developing various fertility services by market players are anticipated to drive growth. An increase in product launches and approvals for advanced fertility services is expected to further enhance regional market growth in the coming years. Due to rising infertility rates, a trend towards later pregnancies, improved IVF success rates, and growing disposable incomes, the market in Asia Pacific is expected to experience significant growth during the forecast period. IVF is one of the most commonly utilized methods to assist individuals affected by infertility, including single mothers, couples, and members of the LGBT community. Furthermore, the IVF treatment market in Asia Pacific has sustainable development potential due to the rise in fertility tourism. The growth of the market is also expected to be supported by the increasing number of fertility clinics and expansion opportunities in emerging regions.

Fertility Services Market Report Scope

Industry Developments and Future Opportunities - Fertility Services Market:According to press releases from leading companies in the fertility services market, several initiatives are highlighted below:

In October 2022, Indira IVF partnered with Maven Clinic, a US-based company specializing in women's and family health through telemedicine-based virtual clinics. This collaboration aims to provide Maven members in India with access to Indira IVF's high-quality clinical care and other benefits through the Maven platform.In August 2022, Genea Fertility served as a Platinum Sponsor at the Australian Jewish Fertility Network's (AJFN) Annual Major Fundraiser.In December 2021, Cooper Surgical, a leading provider of women's health solutions, acquired Generate Life Sciences for US$1.6 billion, enhancing its offerings in fertility and OB/GYN centers.

In July 2021, Hamilton Throne Ltd., a global provider of ART research, acquired IVFTECH ApS (IVFtech) and its subsidiary K4 Technology ApS for US$8 million, focusing on large-capacity laminar flow workstations and incubators for ART.In May 2021, Virtus Health, a global leader in Assisted Reproductive Services (ARS), announced a strategic collaboration with Drop Bio, an Australian biotechnology and digital health company, to advance precision fertility delivery.

In February 2021, Cooper Surgical announced a multi-year strategic collaboration with Virtus Health to drive innovation and advancements in fertility treatment.In November 2020, Ferring B.V. and Igenomix entered into a four-year research collaboration to develop novel therapeutic products for patients affected by pregnancy-related diseases.

Competitive Landscape and Key Companies - Fertility Services Market:Key players in the fertility services market include CooperSurgical, Inc.; Vitrolife; Cook Medical; Care Fertility; INVO Bioscience; Carolinas Fertility Institute; Genea Limited; Merck KgaA; LABOTECT GmbH; and Monash IVF Group Limited. These companies are focused on developing new technologies, enhancing existing products, and expanding geographically to meet the growing global demand.